Target intelligence / Profile preview

Pseudomonas aeruginosa virulence and motility machinery

Molecular classification
Other, Enzyme, Transcription factor, Transporter, Secretory system
01

Overview

Pseudomonas aeruginosa virulence and motility machinery refers to the collective set of molecular mechanisms that enable this opportunistic pathogen to colonize hosts, evade immune responses, and cause tissue damage. This machinery includes the Type III Secretion System (T3SS), which delivers effector toxins directly into host cells, and complex quorum sensing (QS) circuits (Las, Rhl, and PQS systems) that regulate the expression of extracellular proteases and pigments like pyocyanin (Hauser, 2009; Lee & Zhang, 2015). Additionally, the bacterium utilizes flagella for swimming and Type IV pili for twitching motility, both of which are essential for the initial stages of biofilm formation and surface attachment (Burrows, 2012). Because these systems are vital for pathogenesis but often non-essential for basic bacterial growth, they are prime targets for anti-virulence therapies designed to reduce disease severity without driving the rapid development of antibiotic resistance (Dickey et al., 2017). Therapeutic approaches currently under investigation include the use of QS inhibitors, T3SS blockers, and iron-chelating agents to disrupt the bacterium's ability to thrive and disseminate within the host environment.

Other names
P. aeruginosa virulence factorsAnti-virulence targetsBacterial motility systemsPseudomonas pathogenesis machinery
02

Mechanism of action

Inhibition of quorum sensing (QS) signaling pathways, blockade of the Type III Secretion System (T3SS) needle complex or effector translocation, disruption of flagellar and Type IV pili assembly, and sequestration of essential nutrients such as iron to prevent bacterial colonization and tissue damage.

03

Biological functions

Bacterial pathogenesisCell motilitySignal transductionBiofilm formationIron acquisitionProtein secretion
04

Disease associations

InfectionCystic fibrosisPneumoniaSepsisChronic wound infection
05

Safety considerations

Potential for off-target effects on the host microbiomeDifficulty in achieving therapeutic concentrations within thick mucus (e.g., in cystic fibrosis lungs)Risk of selecting for compensatory mutations in alternative virulence pathwaysLimited efficacy as monotherapy in acute, high-burden infections
06

Interacting drugs

Azithromycin

4 more in the full profile.

07

Biomarkers

Pyocyanin levelsElastase B (LasB) activityExoS/ExoU effector secretionBiofilm biomassRhamnolipid production

Beyond the preview

Go deeper on Pseudomonas aeruginosa virulence and motility machinery.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pseudomonas aeruginosa virulence and motility machinery.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call